Funding Opportunities and Deadlines

Research Priority

Behavioral Health and Psychology

Application Due
(Letter of Intent Required)

November 21

Telehealth in Type 1 Diabetes Behavioral Health and Psychology

Details

Milestone Date Status
Letter of Intent Required Oct 03, 2019 Passed
Application Nov 21, 2019 Next
Award Notification Mar 01, 2020
Earliest Start May 01, 2020
Behavioral Health and Psychology

Application Due

December 04

JDRF Diabetes Psychology Postdoctoral Fellowship Program

Details

Milestone Date Status
Letter of Intent N/A
Application Dec 04, 2019 Next
Award Notification Mar 01, 2020
Earliest Start Jul 01, 2020
Beta Cell Replacement Therapies

Application Due
(Letter of Intent Required)

November 14

3D Bioprinting and Biofabrication of Rationally Designed Engineered Tissue Constructs as Therapeutic Products for Treatment of Type 1 Diabetes (T1D)

Details

Milestone Date Status
Letter of Intent Required Sep 16, 2019 Passed
Application Nov 14, 2019 Next
Award Notification Apr 30, 2020
Earliest Start Jun 30, 2020
Immunotherapies

Application Due
(Letter of Intent Required)

October 31

Therapeutic Development and Clinical Testing of Immune Therapies for Type 1 Diabetes

Details

Milestone Date Status
Letter of Intent Required Aug 05, 2019 Passed
Application Oct 31, 2019 Next
Award Notification Mar 31, 2020
Earliest Start May 01, 2020
Immunotherapies

Application Due
(Letter of Intent Required)

December 03

Decoding Immune Mediated Diseases – Novel Approaches for Therapeutic Insights

Details

Milestone Date Status
Letter of Intent Required Sep 09, 2019 Passed
Application Dec 03, 2019 Next
Award Notification May 31, 2020
Earliest Start Aug 01, 2020
Metabolic Control

Letter of Intent Due

October 28

Safe and Effective Use of SGLT Inhibitors for Type 1 Diabetes

Details

Milestone Date Status
Letter of Intent Oct 28, 2019 Next
Application Jan 08, 2020
Award Notification May 31, 2020
Earliest Start Aug 31, 2020
Metabolic Control

Application Due
(Letter of Intent Required)

November 14

Repositioning Drugs to Improve Metabolic Control in Established Type 1 Diabetes

Details

Milestone Date Status
Letter of Intent Required Sep 26, 2019 Passed
Application Nov 14, 2019 Next
Award Notification Mar 31, 2020
Earliest Start Jul 01, 2020
Prevention

Letter of Intent Due

November 06

The Role of the Microbiome in Type 1 Diabetes: Pathogenesis and Therapeutic Utility

Details

Milestone Date Status
Letter of Intent Nov 06, 2019 Next
Application Jan 07, 2020
Award Notification Apr 30, 2020
Earliest Start Jul 01, 2020

Ongoing Opportunities

These funding sources are typically available annually or ongoing

Conference Grants

Industry Discovery & Development Partnerships

JDRF Impact Grants
Nov 01

Project Concepts (Strategic Research Agreement)
Nov 04

Early-Career Patient-Oriented Diabetes Research Awards (projects in COMPLICATIONS are ineligible)
Jan 31

Career Development Awards (projects in COMPLICATIONS are ineligible)
Jan 31

Advanced Postdoctoral Fellowships (projects in COMPLICATIONS are ineligible)
Jan 31

Postdoctoral Fellowships (projects in COMPLICATIONS are ineligible)
Jan 31

RFAs Awaiting Notification

Nov

Neoepitopes in Type 1 Diabetes: Pathogenesis, Staging, and Therapeutic Utility
Jan

Optimization and Clinical Validation of Islet Autoantibody Assays for Screening for Type One Diabetes Risk
Jan

Beta Cell Replacement Innovative Awards
Jan

Metabolic Control Innovative Awards
Jan

Immunotherapies Innovative Awards
Feb

Validation of T Cell Biomarkers and Assays for T1D